Effect of treating co-infections on HIV-1 viral load: a systematic review

The Lancet Infectious Diseases

Volumn 10, Issue 7, 2010, Pages 455-463

  Modjarrad, Kayvon ^a   Vermund, Sten H ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; VIRUS RNA;

ANCYLOSTOMA DUODENALE; ASCARIS LUMBRICOIDES; CD4 LYMPHOCYTE COUNT; CLINICAL TRIAL; DISEASE COURSE; FILARIA; FILARIASIS; GONORRHEA; HELMINTH; HELMINTHIASIS; HERPES SIMPLEX VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; KENYA; LOWEST INCOME GROUP; MALARIA; META ANALYSIS; MIXED INFECTION; MYCOBACTERIUM TUBERCULOSIS; NECATOR AMERICANUS; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; SCHISTOSOMA; SCHISTOSOMIASIS; SEXUALLY TRANSMITTED DISEASE; SYPHILIS; SYSTEMATIC REVIEW; THERAPY EFFECT; TRICHURIS; TUBERCULOSIS; UNITED STATES; VIRUS LOAD; VIRUS TRANSMISSION;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ANTI-RETROVIRAL AGENTS; COMMUNICABLE DISEASES; HERPES SIMPLEX; HIV INFECTIONS; HIV-1; HUMANS; MALARIA; PARASITIC DISEASES; RNA, VIRAL; SYPHILIS; TUBERCULOSIS; VIRAL LOAD;

EID: 77953631013     PISSN: 14733099     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1473-3099(10)70093-1     Document Type: Review

References (99)

1. WHO. Towards universal access: scaling up priority HIV/AIDS interventions in the health sector. Progress report (2009), World Health Organization, Geneva
2. Fauci A.S. Multifactorial nature of human immunodeficiency virus disease: implications for therapy. Science 262 (1993) 1011-1018
3. Bentwich Z. Concurrent infections that rise the HIV viral load. J HIV Ther 8 (2003) 72-75
4. Stein D.S. Herpes virus infections, HIV, and disease progression. AIDS Clin Care 7 (1995) 11-14 18.
5. Webster A. Cytomegalovirus as a possible cofactor in HIV disease progression. J Acquir Immune Defic Syndr 4 suppl 1 (1991) S47-S52
6. Goletti D., Weissman D., Jackson R.W., et al. Effect of Mycobacterium tuberculosis on HIV replication. Role of immune activation. J Immunol 157 (1996) 1271-1278
7. Kallestrup P., Zinyama R., Gomo E., et al. Schistosomiasis and HIV-1 infection in rural Zimbabwe: effect of treatment of schistosomiasis on CD4 cell count and plasma HIV-1 RNA load. J Infect Dis 192 (2005) 1956-1961
8. Lawn S.D., Karanja D.M., Mwinzia P., et al. The effect of treatment of schistosomiasis on blood plasma HIV-1 RNA concentration in coinfected individuals. AIDS 14 (2000) 2437-2443
9. Walson J.L., and John-Stewart G. Treatment of helminth co-infection in HIV-1 infected individuals in resource-limited settings. Cochrane Database Syst Rev 1 (2008) CD006419.
10. Schacker T., Zeh J., Hu H., Shaughnessy M., and Corey L. Changes in plasma human immunodeficiency virus type 1 RNA associated with herpes simplex virus reactivation and suppression. J Infect Dis 186 (2002) 1718-1725
11. Hoffman I.F., Jere C.S., Taylor T.E., et al. The effect of Plasmodium falciparum malaria on HIV-1 RNA blood plasma concentration. AIDS 13 (1999) 487-494
12. Kublin J.G., Patnaik P., Jere C.S., et al. Effect of Plasmodium falciparum malaria on concentration of HIV-1-RNA in the blood of adults in rural Malawi: a prospective cohort study. Lancet 365 (2005) 233-240
13. Bentwich Z., Kalinkovich A., and Weisman Z. Immune activation is a dominant factor in the pathogenesis of African AIDS. Immunol Today 16 (1995) 187-191
14. Borkow G., and Bentwich Z. Chronic immune activation associated with chronic helminthic and human immunodeficiency virus infections: role of hyporesponsiveness and anergy. Clin Microbiol Rev 17 (2004) 1012-1030
15. Pisell T.L., Hoffman I.F., Jere C.S., et al. Immune activation and induction of HIV-1 replication within CD14 macrophages during acute Plasmodium falciparum malaria coinfection. AIDS 16 (2002) 1503-1509
16. Sulkowski M.S., Chaisson R.E., Karp C.L., Moore R.D., Margolick J.B., and Quinn T.C. The effect of acute infectious illnesses on plasma human immunodeficiency virus (HIV) type 1 load and the expression of serologic markers of immune activation among HIV-infected adults. J Infect Dis 178 (1998) 1642-1648
17. Weissman D., Barker T.D., and Fauci A.S. The efficiency of acute infection of CD4+ T cells is markedly enhanced in the setting of antigen-specific immune activation. J Exp Med 183 (1996) 687-692
18. Celum C.L. The interaction between herpes simplex virus and human immunodeficiency virus. Herpes 11 suppl 1 (2004) 36A-45A
19. Mercader M., Nickoloff B.J., and Foreman K.E. Induction of human immunodeficiency virus 1 replication by human herpesvirus 8. Arch Pathol Lab Med 125 (2001) 785-789
20. Modjarrad K., Chamot E., and Vermund S.H. Impact of small reductions in plasma HIV RNA levels on the risk of heterosexual transmission and disease progression. AIDS 22 (2008) 2179-2185
21. Moher D., Cook D.J., Eastwood S., Olkin I., Rennie D., and Stroup D.F. Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Lancet 354 (1999) 1896-1900
22. Liberati A., Altman D.G., Tetzlaff J., et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol 62 (2009) e1-e34
23. von Elm E., Altman D.G., Egger M., Pocock S.J., Gotzsche P.C., and Vandenbroucke J.P. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Ann Intern Med 147 (2007) 573-577
24. Kizza H.M., Rodriguez B., Quinones-Mateu M., et al. Persistent replication of human immunodeficiency virus type 1 despite treatment of pulmonary tuberculosis in dually infected subjects. Clin Diagn Lab Immunol 12 (2005) 1298-1304
25. Walson J.L., Otieno P.A., Mbuchi M., et al. Albendazole treatment of HIV-1 and helminth co-infection: a randomized, double-blind, placebo-controlled trial. AIDS 22 (2008) 1601-1609
26. Nagot N., Ouedraogo A., Foulongne V., et al. Reduction of HIV-1 RNA levels with therapy to suppress herpes simplex virus. N Engl J Med 356 (2007) 790-799
27. Zuckerman R.A., Lucchetti A., Whittington W.L., et al. Herpes simplex virus (HSV) suppression with valacyclovir reduces rectal and blood plasma HIV-1 levels in HIV-1/HSV-2-seropositive men: a randomized, double-blind, placebo-controlled crossover trial. J Infect Dis 196 (2007) 1500-1508
28. Anzala A.O., Simonsen J.N., Kimani J., et al. Acute sexually transmitted infections increase human immunodeficiency virus type 1 plasma viremia, increase plasma type 2 cytokines, and decrease CD4 cell counts. J Infect Dis 182 (2000) 459-466
29. Brown M., Kizza M., Watera C., et al. Helminth infection is not associated with faster progression of HIV disease in coinfected adults in Uganda. J Infect Dis 190 (2004) 1869-1879
30. Modjarrad K., Zulu I., Redden D.T., et al. Treatment of intestinal helminths does not reduce plasma concentrations of HIV-1 RNA in coinfected Zambian adults. J Infect Dis 192 (2005) 1277-1283
31. Nielsen N.O., Friis H., Magnussen P., Krarup H., Magesa S., and Simonsen P.E. Co-infection with subclinical HIV and Wuchereria bancrofti, and the role of malaria and hookworms, in adult Tanzanians: infection intensities, CD4/CD8 counts and cytokine responses. Trans R Soc Trop Med Hyg 101 (2007) 602-612
32. Wolday D., Mayaan S., Mariam Z.G., et al. Treatment of intestinal worms is associated with decreased HIV plasma viral load. J Acquir Immune Defic Syndr 31 (2002) 56-62
33. Baeten J.M., Strick L.B., Lucchetti A., et al. Herpes simplex virus (HSV)-suppressive therapy decreases plasma and genital HIV-1 levels in HSV-2/HIV-1 coinfected women: a randomized, placebo-controlled, cross-over trial. J Infect Dis 198 (2008) 1804-1808
34. Sadiq S.T., McSorley J., Copas A.J., et al. The effects of early syphilis on CD4 counts and HIV-1 RNA viral loads in blood and semen. Sex Transm Infect 81 (2005) 380-385
35. Ouedraogo A., Nagot N., Vergne L., et al. Impact of suppressive herpes therapy on genital HIV-1 RNA among women taking antiretroviral therapy: a randomized controlled trial. AIDS 20 (2006) 2305-2313
36. Celum C., Wald A., Lingappa J.R., et al. Acyclovir and transmission of HIV-1 from persons infected with HIV-1 and HSV-2. N Engl J Med 362 (2010) 427-439
37. Bartlett J.A., DeMasi R., Dawson D., and Hill A. Variability in repeated consecutive measurements of plasma human immunodeficiency virus RNA in persons receiving stable nucleoside reverse transcriptase inhibitor therapy or no treatment. J Infect Dis 178 (1998) 1803-1805
38. Brambilla D., Reichelderfer P.S., Bremer J.W., et al. The contribution of assay variation and biological variation to the total variability of plasma HIV-1 RNA measurements. AIDS 13 (1999) 2269-2279
39. Yamashita T.E., Modjarrad K., and Munoz A. Variability of HIV-1 RNA before AIDS and highly active antiretroviral therapy. AIDS 17 (2003) 1264-1266
40. Whalen C.C., Nsubuga P., Okwera A., et al. Impact of pulmonary tuberculosis on survival of HIV-infected adults: a prospective epidemiologic study in Uganda. AIDS 14 (2000) 1219-1228
41. Day J.H., Grant A.D., Fielding K.L., et al. Does tuberculosis increase HIV load?. J Infect Dis 190 (2004) 1677-1684
42. Collins K.R., Quinones-Mateu M.E., Toossi Z., and Arts E.J. Impact of tuberculosis on HIV-1 replication, diversity, and disease progression. AIDS Rev 4 (2002) 165-176
43. Corbett E.L., and De Cock K.M. The clinical significance of interactions between HIV and TB: more questions than answers. Int J Tuberc Lung Dis 5 (2001) 205-207
44. Del Amo J., Malin A.S., Pozniak A., and De Cock K.M. Does tuberculosis accelerate the progression of HIV disease? Evidence from basic science and epidemiology. AIDS 13 (1999) 1151-1158
45. Hoshino Y., Tse D.B., Rochford G., et al. Mycobacterium tuberculosis-induced CXCR4 and chemokine expression leads to preferential X4 HIV-1 replication in human macrophages. J Immunol 172 (2004) 6251-6258
46. Kalou M., Sassan-Morokro M., Abouya L., et al. Changes in HIV RNA viral load, CD4+ T-cell counts, and levels of immune activation markers associated with anti-tuberculosis therapy and cotrimoxazole prophylaxis among HIV-infected tuberculosis patients in Abidjan, Cote d'Ivoire. J Med Virol 75 (2005) 202-208
47. Lawn S.D., Shattock R.J., Acheampong J.W., et al. Sustained plasma TNF-alpha and HIV-1 load despite resolution of other parameters of immune activation during treatment of tuberculosis in Africans. AIDS 13 (1999) 2231-2237
48. Morris L., Martin D.J., Bredell H., et al. Human immunodeficiency virus-1 RNA levels and CD4 lymphocyte counts, during treatment for active tuberculosis, in South African patients. J Infect Dis 187 (2003) 1967-1971
49. Schon T., Wolday D., Elias D., et al. Kinetics of sedimentation rate, viral load and TNF-alpha in relation to HIV co-infection in tuberculosis. Trans R Soc Trop Med Hyg 100 (2006) 483-488
50. Toossi Z., Mayanja-Kizza H., Hirsch C.S., et al. Impact of tuberculosis (TB) on HIV-1 activity in dually infected patients. Clin Exp Immunol 123 (2001) 233-238
51. Lawn S.D., Pisell T.L., Hirsch C.S., Wu M., Butera S.T., and Toossi Z. Anatomically compartmentalized human immunodeficiency virus replication in HLA-DR+ cells and CD14+ macrophages at the site of pleural tuberculosis coinfection. J Infect Dis 184 (2001) 1127-1133
52. Nakata K., Rom W.N., Honda Y., et al. Mycobacterium tuberculosis enhances human immunodeficiency virus-1 replication in the lung. Am J Respir Crit Care Med 155 (1997) 996-1003
53. Kirschner D. Dynamics of co-infection with M tuberculosis and HIV-1. Theor Popul Biol 55 (1999) 94-109
54. Xiao L., Owen S.M., Rudolph D.L., Lal R.B., and Lal A.A. Plasmodium falciparum antigen-induced human immunodeficiency virus type 1 replication is mediated through induction of tumor necrosis factor-alpha. J Infect Dis 177 (1998) 437-445
55. Chen X., Xiao B., Shi W., et al. Impact of acute vivax malaria on the immune system and viral load of HIV-positive subjects. Chin Med J (Engl) 116 (2003) 1810-1820
56. WHO. Malaria and HIV/AIDS interactions and implications: conclusions of a technical consultation convened by WHO, 23-25 June, 2004. WHO/HIV/2004.8. http://whqlibdoc.who.int/hq/2004/WHO_HIV_2004.08_eng.pdf (accessed April 29, 2010).
57. Ariyoshi K., van der Loeff M.S., Berry N., Jaffar S., and Whittle H. Plasma HIV viral load in relation to season and to Plasmodium falciparum parasitaemia. AIDS 13 (1999) 1145-1146
58. Ayouba A., Nerrienet E., Menu E., et al. Mother-to-child transmission of human immunodeficiency virus type 1 in relation to the season in Yaounde, Cameroon. Am J Trop Med Hyg 69 (2003) 447-449
59. Inion I., Mwanyumba F., Gaillard P., et al. Placental malaria and perinatal transmission of human immunodeficiency virus type 1. J Infect Dis 188 (2003) 1675-1678
60. Kashamuka M., Nzila N., Mussey L., et al. Short report: analysis of anti-malaria immune response during human immunodeficiency virus infection in adults in Kinshasa, Democratic Republic of the Congo. Am J Trop Med Hyg 68 (2003) 376-378
61. Ayisi J.G., van Eijk A.M., Newman R.D., et al. Maternal malaria and perinatal HIV transmission, western Kenya. Emerg Infect Dis 10 (2004) 643-652
62. Brahmbhatt H., Kigozi G., Wabwire-Mangen F., et al. The effects of placental malaria on mother-to-child HIV transmission in Rakai, Uganda. AIDS 17 (2003) 2539-2541
63. Brahmbhatt H., Sullivan D., Kigozi G., et al. Association of HIV and malaria with mother-to-child transmission, birth outcomes, and child mortality. J Acquir Immune Defic Syndr 47 (2008) 472-476
64. Kapiga S.H., Bang H., Spiegelman D., et al. Correlates of plasma HIV-1 RNA viral load among HIV-1-seropositive women in Dar es Salaam, Tanzania. J Acquir Immune Defic Syndr 30 (2002) 316-323
65. Borkow G., Leng Q., Weisman Z., et al. Chronic immune activation associated with intestinal helminth infections results in impaired signal transduction and anergy. J Clin Invest 106 (2000) 1053-1060
66. Kalinkovich A., Weisman Z., and Bentwich Z. Chemokines and chemokine receptors: role in HIV infection. Immunol Lett 68 (1999) 281-287
67. Messele T., Abdulkadir M., Fontanet A.L., et al. Reduced naive and increased activated CD4 and CD8 cells in healthy adult Ethiopians compared with their Dutch counterparts. Clin Exp Immunol 115 (1999) 443-450
68. Bentwich Z., Weisman Z., Moroz C., Bar-Yehuda S., and Kalinkovich A. Immune dysregulation in Ethiopian immigrants in Israel: relevance to helminth infections?. Clin Exp Immunol 103 (1996) 239-243
69. Kalinkovich A., Borkow G., Weisman Z., Tsimanis A., Stein M., and Bentwich Z. Increased CCR5 and CXCR4 expression in Ethiopians living in Israel: environmental and constitutive factors. Clin Immunol 100 (2001) 107-117
70. Bentwich Z. Good worms or bad worms: do worm infections affect the epidemiological patterns of other diseases?. Parasitol Today 16 (2000) 312
71. Galai N., Kalinkovich A., Burstein R., Vlahov D., and Bentwich Z. African HIV-1 subtype C and rate of progression among Ethiopian immigrants in Israel. Lancet 349 (1997) 180-181
72. Weisman Z., Kalinkovich A., Borkow G., Stein M., Greenberg Z., and Bentwich Z. Infection by different HIV-1 subtypes (B and C) results in a similar immune activation profile despite distinct immune backgrounds. J Acquir Immune Defic Syndr 21 (1999) 157-163
73. Elliott A.M., Mawa P.A., Joseph S., et al. Associations between helminth infection and CD4+ T cell count, viral load and cytokine responses in HIV-1-infected Ugandan adults. Trans R Soc Trop Med Hyg 97 (2003) 103-108
74. Gray R.H., Wawer M.J., Brookmeyer R., et al. Probability of HIV-1 transmission per coital act in monogamous, heterosexual, HIV-1-discordant couples in Rakai, Uganda. Lancet 357 (2001) 1149-1153
75. Grosskurth H., Mosha F., Todd J., et al. Impact of improved treatment of sexually transmitted diseases on HIV infection in rural Tanzania: randomised controlled trial. Lancet 346 (1995) 530-536
76. Rotchford K., Strum A.W., and Wilkinson D. Effect of coinfection with STDs and of STD treatment on HIV shedding in genital-tract secretions: systematic review and data synthesis. Sex Transm Dis 27 (2000) 243-248
77. Chakraborty H., Sen P.K., Helms R.W., et al. Viral burden in genital secretions determines male-to-female sexual transmission of HIV-1: a probabilistic empiric model. AIDS 15 (2001) 621-627
78. Sabin C.A., Telfer P., Phillips A.N., Bhagani S., and Lee C.A. The association between hepatitis C virus genotype and human immunodeficiency virus disease progression in a cohort of hemophilic men. J Infect Dis 175 (1997) 164-168
79. Zylberberg H., and Pol S. Reciprocal interactions between human immunodeficiency virus and hepatitis C virus infections. Clin Infect Dis 23 (1996) 1117-1125
80. Brau N. Update on chronic hepatitis C in HIV/HCV-coinfected patients: viral interactions and therapy. AIDS 17 (2003) 2279-2290
81. Negredo E., Domingo P., Sambeat M.A., Rabella N., and Vazquez G. Influence of coinfection with hepatitis viruses on human immunodeficiency plasma viral load. Arch Intern Med 159 (1999) 2367-2368
82. Sabin C.A. Hepatitis C virus and HIV coinfection. AIDS Patient Care STDs 12 (1998) 199-207
83. Jere C., Cunliffe N.A., Hoffman I.F., et al. Plasma HIV burden in Malawian children co-infected with rotavirus. AIDS 15 (2001) 1439-1442
84. Lefrere J.J., Roudot-Thoraval F., Morand-Joubert L., et al. Carriage of GB virus C/hepatitis G virus RNA is associated with a slower immunologic, virologic, and clinical progression of human immunodeficiency virus disease in coinfected persons. J Infect Dis 179 (1999) 783-789
85. Pintado V., Martin-Rabadan P., Rivera M.L., Moreno S., and Bouza E. Visceral leishmaniasis in human immunodeficiency virus (HIV)-infected and non-HIV-infected patients. A comparative study. Medicine (Baltimore) 80 (2001) 54-73
86. Preiser W., Cacopardo B., Nigro L., et al. Immunological findings in HIV-Leishmania coinfection. Intervirology 39 (1996) 285-288
87. Zhao C., Papadopoulou B., and Tremblay M.J. Leishmania infantum enhances human immunodeficiency virus type-1 replication in primary human macrophages through a complex cytokine network. Clin Immunol 113 (2004) 81-88
88. Berhe N., Wolday D., Hailu A., et al. HIV viral load and response to antileishmanial chemotherapy in co-infected patients. AIDS 13 (1999) 1921-1925
89. Shaunak S., Veryard C., and Javan C. Severe Pneumocystis carinii pneumonia increases the infectious titre of HIV-1 in blood and can promote the expansion of viral chemokine co-receptor tropism. J Infect 43 (2001) 3-6
90. Brichacek B., Swindells S., Janoff E.N., Pirruccello S., and Stevenson M. Increased plasma human immunodeficiency virus type 1 burden following antigenic challenge with pneumococcal vaccine. J Infect Dis 174 (1996) 1191-1199
91. Couch R.B. Influenza, influenza virus vaccine, and human immunodeficiency virus infection. Clin Infect Dis 28 (1999) 548-551
92. Donovan R.M., Moore E., Bush C.E., Markowitz N.P., and Saravolatz L.D. Changes in plasma HIV RNA levels and CD4 cell counts after vaccination of pediatric patients. AIDS 11 (1997) 1054-1056
93. Ho D.D. HIV-1 viraemia and influenza. Lancet 339 (1992) 1549
94. O'Brien W.A., Grovit-Ferbas K., Namazi A., et al. Human immunodeficiency virus-type 1 replication can be increased in peripheral blood of seropositive patients after influenza vaccination. Blood 86 (1995) 1082-1089
95. Ramilo O., Hicks P.J., Borvak J., et al. T cell activation and human immunodeficiency virus replication after influenza immunization of infected children. Pediatr Infect Dis J 15 (1996) 197-203
96. Stanley S.K., Ostrowski M.A., Justement J.S., et al. Effect of immunization with a common recall antigen on viral expression in patients infected with human immunodeficiency virus type 1. N Engl J Med 334 (1996) 1222-1230
97. Vigano A., Bricalli D., Trabattoni D., et al. Immunization with both T cell-dependent and T cell-independent vaccines augments HIV viral load secondarily to stimulation of tumor necrosis factor α. AIDS Res Hum Retroviruses 14 (1998) 727-734
98. Schneider R.F., and Rosen M.J. Pneumococcal infections in HIV-infected adults. Semin Respir Infect 14 (1999) 237-242
99. Zanetti A.R., Amendola A., Besana S., Boschini A., and Tanzi E. Safety and immunogenicity of influenza vaccination in individuals infected with HIV. Vaccine 20 suppl 5 (2002) B29-B32